Submitted by Anonymous (not verified) on 26 January 2026 - 15:44
Human medicines European public assessment report (EPAR): Tovanor Breezhaler, glycopyrronium bromide, Date of authorisation: 28/09/2012, Revision: 17, Status: Authorised
Source:
